Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Avera McKennan Hospital & University Health Center
M.D. Anderson Cancer Center
Cancer Research UK
Carevive Systems, Inc.
Essen Biotech
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Adela, Inc
Memorial Sloan Kettering Cancer Center
Cancer Research UK
University Health Network, Toronto
Cancer Research UK
Massive Bio, Inc.
Incyte Corporation
Washington University School of Medicine
Tempus AI
University Health Network, Toronto
Stanford University
Taproot Health
Sellas Life Sciences Group
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
MacroGenics
Sumitomo Pharma America, Inc.
Eisai Inc.
Scripps Health
Blue Note Therapeutics
Weprom
Celgene
Chinese PLA General Hospital
Shenzhen BinDeBio Ltd.
Vanderbilt-Ingram Cancer Center
Novartis
CureOne
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
Novartis
University of Minnesota
Rutgers, The State University of New Jersey
Barbara Ann Karmanos Cancer Institute
Eastern Cooperative Oncology Group
PX Biosolutions
Indiana University
Children's Oncology Group